Predicting conversion to wet age-related macular degeneration using deep learning.

Journal: Nature medicine
Published Date:

Abstract

Progression to exudative 'wet' age-related macular degeneration (exAMD) is a major cause of visual deterioration. In patients diagnosed with exAMD in one eye, we introduce an artificial intelligence (AI) system to predict progression to exAMD in the second eye. By combining models based on three-dimensional (3D) optical coherence tomography images and corresponding automatic tissue maps, our system predicts conversion to exAMD within a clinically actionable 6-month time window, achieving a per-volumetric-scan sensitivity of 80% at 55% specificity, and 34% sensitivity at 90% specificity. This level of performance corresponds to true positives in 78% and 41% of individual eyes, and false positives in 56% and 17% of individual eyes at the high sensitivity and high specificity points, respectively. Moreover, we show that automatic tissue segmentation can identify anatomical changes before conversion and high-risk subgroups. This AI system overcomes substantial interobserver variability in expert predictions, performing better than five out of six experts, and demonstrates the potential of using AI to predict disease progression.

Authors

  • Jason Yim
    DeepMind, London, UK.
  • Reena Chopra
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom.
  • Terry Spitz
    Google Health, London, UK.
  • Jim Winkens
    Google Health, London, UK.
  • Annette Obika
    DeepMind, London, UK.
  • Christopher Kelly
    Google Health, London, UK.
  • Harry Askham
    DeepMind, London, UK.
  • Marko Lukic
    NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
  • Josef Huemer
    Moorfields Eye Hospital, London, United Kingdom.
  • Katrin Fasler
    NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
  • Gabriella Moraes
    Medical Retina Department, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Clemens Meyer
    DeepMind, London, UK.
  • Marc Wilson
    Google Health, London, UK.
  • Jonathan Dixon
    Google Health, London, UK.
  • Cian Hughes
    Google Health, London, UK.
  • Geraint Rees
    Institute of Neurology, University College London, London, WC1N 3BG, UK.
  • Peng T Khaw
    NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
  • Alan Karthikesalingam
    Department of Outcomes Research, St George's Vascular Institute, London, SW17 0QT, United Kingdom.
  • Dominic King
    DeepMind, London, UK.
  • Demis Hassabis
    Google DeepMind, 5 New Street Square, London EC4A 3TW, UK.
  • Mustafa Suleyman
    DeepMind, London, UK.
  • Trevor Back
    DeepMind, London, EC4A 3TW, UK.
  • Joseph R Ledsam
    DeepMind, London, UK.
  • Pearse A Keane
    National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Jeffrey De Fauw
    DeepMind, London, EC4A 3TW, UK.